Horizon Pharma (HZNP) Spikes on Q2 Resuylts

August 8, 2016 12:35 PM | 9 seconds read | Make a Comment
Loading...
Loading...
Horizon Pharma PLC
HZNP
shares rose 6.5% to $21.40 after the company reported better-than-expected Q2 results. Share volume was 8.1 million, double its all-day average
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!